Tandem Diabetes Care, Inc. is a medical device company headquartered in San Diego, California, which specializes in the design, development, and commercialization of insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the t:slim X2 insulin delivery system, includes a pump, a 300-unit disposable insulin cartridge, and an infusion set. The company offers advanced features such as Basal-IQ Technology and Control-IQ Technology, along with the Tandem Device Updater for software enhancements. Additionally, Tandem provides the t:connect web-based data management application and the Sugarmate mobile app to support diabetes management for users and their caregivers. Tandem Diabetes Care entered the insulin pump market in 2012 and has since expanded its product line, including the recent launch of the smaller Mobi pump and development of a tubeless pump. The majority of the company’s revenue is generated in the United States, with additional sales from other developed countries.
AMF Medical is focused on developing Sigi, an innovative patch pump designed to administer insulin with exceptional ease of use. This novel device is intended for seamless integration into closed loop systems, compatible with third-party Continuous Glucose Monitoring products and dose-calculating algorithms. The company's mission is to alleviate the therapy burden faced by individuals with diabetes, ultimately aiming to enhance their quality of life. AMF Medical was established in early 2021 as a spin-off from Advanced Microfluidics, which specializes in high-end lab equipment components that utilize related technologies.
Advanced Microfluidics
Corporate Round in 2022
AMF Medical is focused on developing Sigi, an innovative patch pump designed to administer insulin with exceptional ease of use. This novel device is intended for seamless integration into closed loop systems, compatible with third-party Continuous Glucose Monitoring products and dose-calculating algorithms. The company's mission is to alleviate the therapy burden faced by individuals with diabetes, ultimately aiming to enhance their quality of life. AMF Medical was established in early 2021 as a spin-off from Advanced Microfluidics, which specializes in high-end lab equipment components that utilize related technologies.
Capillary Biomedical
Acquisition in 2022
Capillary Biomedical, Inc. is a medical device company founded in 2014 and located in Irvine, California. The company focuses on developing innovative technologies for diabetes management, particularly in simplifying glucose monitoring and insulin delivery. As a spin-out from the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University, Capillary Biomedical is dedicated to reducing the burden of diabetes on patients and the healthcare system. Its flagship product features a kink-proof, flexible, multiport cannula designed for reliable and comfortable insulin delivery, with an emphasis on a straightforward one-handed insertion process. This user-friendly design aims to assist diabetes patients in achieving better blood glucose control.
CeQur Simplicity
Series C in 2021
CeQur Simplicity focuses on improving the lives of individuals with diabetes by creating innovative drug-delivery devices. The company has developed a discreet and wearable insulin delivery device that simplifies the administration of both basal and bolus insulin for up to three days. This technology enables patients to effectively engage in intensive insulin therapy without the daily inconvenience of injections. By collaborating with healthcare professionals and diabetes centers, CeQur Simplicity aims to enhance patient care and accessibility to its user-friendly insulin delivery solutions.
Sugarmate
Acquisition in 2020
Sugarmate Inc. is a digital health company that specializes in developing a companion application for users of the Dexcom G5 and G6 continuous glucose monitoring systems. The application provides users with real-time alerts for glucose readings, enabling them to receive notifications when levels drop below normal. It allows users to communicate their location to friends and family in case of a severe drop in blood sugar and offers customizable alerts for various glucose level changes. Additionally, the app assists users in tracking their food intake, exercise, insulin, and medication, while providing data visualization tools that help in managing diabetes effectively. Sugarmate's features include synchronization with other food tracking applications, event logging for physical activities, and voice recognition for easy access to nutritional information. Founded in 2015 and based in New York, Sugarmate operates as a subsidiary of Tandem Diabetes Care, serving patients, caregivers, and healthcare professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.